Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Brefeldin A, an effector of Ascochyta medicaginicola, mediates virulence.

Created on 17 Sep 2026

Authors

Xunfeng Chen, Yanxiu Pan, Yanru Lan, Zhibiao Nan, Peng Gao, Qiuyan Song

Published in

Plant disease. Sep 16, 2026. Epub Sep 16, 2026.

Abstract

Alfalfa spring black stem, caused by Ascochyta medicaginicola, severely affects global alfalfa production. This study isolates and identifies brefeldin A (BFA) from pathogen fermentation products and demonstrates its strong phytotoxicity. BFA inhibits leaf photosynthesis and seed germination in a dose-dependent manner at concentrations ≥10-4 mol. Significant variation in BFA sensitivity is observed among cultivars, with 'Longdong' showing the highest susceptibility and 'Spyder' displaying relative resistance. LC-MS/MS analysis detects BFA in naturally infected plants, confirming its presence during disease development. BFA treatment increases leaf relative electrolyte leakage, reduces chlorophyll content, and induces chloroplast structural damage, including shrinkage and disintegration of grana lamellae. Furthermore, BFA enhances defense-related enzyme activities and alters the expression of 953 genes. Gene set enrichment analysis reveals that photosynthesis pathways are significantly down-regulated, whereas defense responses are up-regulated. These results identify BFA as a key virulence effector and provide a basis for disease-resistant breeding and ecological management of spring black stem disease.

PMID:
42747908
Bibliographic data and abstract were imported from PubMed on 17 Sep 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement